Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epoxy Compounds | 2 | 2020 | 8 | 1.340 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1647 | 0.980 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2023 | 5 | 0.900 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2020 | 4 | 0.810 |
Why?
|
| Lipids | 1 | 2023 | 272 | 0.780 |
Why?
|
| Mitochondria | 3 | 2020 | 552 | 0.760 |
Why?
|
| Rotenone | 1 | 2020 | 18 | 0.710 |
Why?
|
| Fatty Acids | 3 | 2020 | 134 | 0.710 |
Why?
|
| Metabolomics | 1 | 2020 | 73 | 0.680 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 53 | 0.660 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 73 | 0.640 |
Why?
|
| Mitochondrial Dynamics | 1 | 2019 | 56 | 0.630 |
Why?
|
| Metformin | 1 | 2020 | 123 | 0.620 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 559 | 0.610 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 634 | 0.590 |
Why?
|
| Membrane Lipids | 1 | 2016 | 41 | 0.540 |
Why?
|
| Software | 1 | 2020 | 663 | 0.520 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 646 | 0.500 |
Why?
|
| Metabolic Diseases | 2 | 2024 | 52 | 0.440 |
Why?
|
| Fibroblasts | 1 | 2016 | 755 | 0.430 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 2538 | 0.400 |
Why?
|
| Oxidation-Reduction | 3 | 2023 | 385 | 0.390 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 247 | 0.310 |
Why?
|
| 3T3-L1 Cells | 2 | 2019 | 34 | 0.300 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 243 | 0.300 |
Why?
|
| NAD | 2 | 2023 | 68 | 0.280 |
Why?
|
| HeLa Cells | 2 | 2019 | 507 | 0.270 |
Why?
|
| Neoplasms | 4 | 2024 | 3009 | 0.240 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2023 | 8 | 0.230 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 61 | 0.220 |
Why?
|
| Glycerol | 1 | 2023 | 35 | 0.220 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 43 | 0.220 |
Why?
|
| Phosphates | 1 | 2023 | 161 | 0.210 |
Why?
|
| Lymphocyte Activation | 2 | 2023 | 747 | 0.200 |
Why?
|
| Muromegalovirus | 1 | 2021 | 2 | 0.200 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 130 | 0.200 |
Why?
|
| Glycolysis | 2 | 2020 | 135 | 0.200 |
Why?
|
| Metabolic Syndrome | 1 | 2023 | 130 | 0.200 |
Why?
|
| HEK293 Cells | 2 | 2020 | 637 | 0.190 |
Why?
|
| Floxuridine | 1 | 2020 | 12 | 0.180 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 147 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 156 | 0.180 |
Why?
|
| RNA, Ribosomal | 1 | 2020 | 64 | 0.180 |
Why?
|
| Food-Drug Interactions | 1 | 2020 | 19 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 589 | 0.180 |
Why?
|
| Serine | 1 | 2020 | 103 | 0.180 |
Why?
|
| Immunity | 1 | 2020 | 140 | 0.170 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 275 | 0.170 |
Why?
|
| Mice | 5 | 2023 | 11710 | 0.170 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 6 | 0.170 |
Why?
|
| Humans | 13 | 2024 | 88611 | 0.170 |
Why?
|
| Aspartic Acid | 1 | 2019 | 65 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 1057 | 0.160 |
Why?
|
| Methyltransferases | 1 | 2020 | 192 | 0.160 |
Why?
|
| Animals | 9 | 2024 | 27233 | 0.160 |
Why?
|
| MCF-7 Cells | 1 | 2019 | 114 | 0.160 |
Why?
|
| Genes, ras | 1 | 2019 | 98 | 0.160 |
Why?
|
| Polymorphism, Genetic | 1 | 2022 | 825 | 0.160 |
Why?
|
| Transgenes | 1 | 2019 | 185 | 0.160 |
Why?
|
| Electron Transport | 1 | 2018 | 74 | 0.160 |
Why?
|
| Biological Transport | 1 | 2019 | 400 | 0.150 |
Why?
|
| Plasma Cells | 1 | 2018 | 82 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 229 | 0.150 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 315 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 450 | 0.140 |
Why?
|
| Transfection | 1 | 2019 | 914 | 0.140 |
Why?
|
| RNA Interference | 1 | 2018 | 378 | 0.140 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2016 | 5 | 0.140 |
Why?
|
| Oleic Acid | 1 | 2016 | 15 | 0.140 |
Why?
|
| Palmitic Acid | 1 | 2016 | 28 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1945 | 0.130 |
Why?
|
| Triglycerides | 1 | 2016 | 232 | 0.130 |
Why?
|
| Obesity | 1 | 2020 | 972 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1111 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 492 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1868 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 2336 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1977 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2406 | 0.080 |
Why?
|
| Kinetics | 2 | 2020 | 1530 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2023 | 457 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 3202 | 0.060 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 14 | 0.060 |
Why?
|
| Apolipoprotein E2 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2020 | 4 | 0.050 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2020 | 11 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 389 | 0.050 |
Why?
|
| Uracil Nucleotides | 1 | 2020 | 5 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 440 | 0.050 |
Why?
|
| Thymidine | 1 | 2020 | 60 | 0.050 |
Why?
|
| Adiposity | 1 | 2020 | 77 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 160 | 0.050 |
Why?
|
| Genome, Mitochondrial | 1 | 2020 | 27 | 0.040 |
Why?
|
| Folic Acid | 1 | 2020 | 63 | 0.040 |
Why?
|
| Gene Editing | 1 | 2020 | 44 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 119 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 127 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 74 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2020 | 130 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2020 | 352 | 0.040 |
Why?
|
| Methylation | 1 | 2020 | 267 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 253 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 228 | 0.040 |
Why?
|
| Alleles | 1 | 2022 | 1132 | 0.040 |
Why?
|
| Autophagy | 1 | 2020 | 154 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1051 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2020 | 183 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 428 | 0.040 |
Why?
|
| Longevity | 1 | 2018 | 55 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2020 | 605 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1221 | 0.040 |
Why?
|
| Esterification | 1 | 2016 | 7 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2016 | 24 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 82 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 1988 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2016 | 128 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 200 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2009 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 836 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2023 | 3368 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 6723 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 4041 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Female | 1 | 2020 | 45759 | 0.010 |
Why?
|